Total raised
$6.5M
Last: Seed 2023-12
Stage
Seed
Founded
2017
Headcount
7
HQ
Nesher
Sector
Health Tech & Life Sciences
About
AnserBio (previously ExoProTher Medical) is a biomedical start-up developing a novel approach to cancer treatment. The company targets the p53-based tumor suppression mechanism that is mutated in over 60% of cancers, including glioblastoma, colon, bladder, ovarian, and small cell lung cancers. It uses proprietary cell derived nano-particles to deliver healthy p53 and restore the body's natural tumor suppression function with minimal adverse side effects.
The company is in the preclinical stage.
Funding history · 6 rounds · $6.5M total
2023-12
Seed
$4.0M
2023-07
SAFE
$700K
2022-11
SAFE
$750K
2021-12
SAFE
$750K
2021-01
SAFE
$250K
2020-01
Undisclosed Round
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What was AnserBio formerly known as?
- AnserBio was formerly known as ExoProTher Medical.
- When was AnserBio founded?
- AnserBio was founded in January 2017.
- What is AnserBio's primary focus in cancer treatment?
- AnserBio focuses on developing a novel approach to cancer treatment by targeting the p53-based tumor suppression mechanism, which is mutated in over 60% of cancers. They use proprietary cell-derived nanoparticles to deliver healthy p53 protein.
- What is AnserBio's current development stage?
- AnserBio is currently in the preclinical stage of development.
- How many employees does AnserBio currently have?
- AnserBio currently has 7 employees.
- What was AnserBio's first recorded funding round and who was the lead investor?
- AnserBio's first recorded funding round was in January 2020, with ExitValley as a lead investor.
- When did AnserBio raise its most recent Seed round and what was the amount?
- AnserBio raised a Seed round of $4,000,000 in December 2023.
- Which investors participated in AnserBio's SAFE rounds in 2021?
- Israel Biotech Fund participated in AnserBio's SAFE rounds in January and December 2021.
- Which investor participated in AnserBio's SAFE rounds in 2022 and 2023?
- Peregrine Ventures participated in AnserBio's SAFE rounds in November 2022 and July 2023.
- Who are the co-founders of AnserBio?
- The co-founders of AnserBio are Lana Volokh and Dr. Alex Tendler.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & SubstancesNanomaterialsBiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
biotechnologymedical-technologiestherapeuticsoncologycancercell-therapynanotechnology